The patent, which expires in 2043, covers a method of using hydrocortisone oral liquid formulations ... ALKINDI SPRINKLE®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone.
Some results have been hidden because they may be inaccessible to you